Here are the dates when blood spot takers need to start offering parents and carers severe combined immunodeficiency (SCID) screening as part of an evaluation in England.
Liz is clinical projects co-ordinator for severe combined immunodeficiency (SCID), for the NHS Newborn Blood Spot Screening Programme.
The NHS severe combined immunodeficiency (SCID) screening evaluation in England is now scheduled to start from September 2021.
Related content and links
The PHE Screening team
Public Health England (PHE) provides support and advice to the NHS-led national screening programmes. These programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions. PHE also hosts the UK National Screening Committee (UK NSC) secretariat and supports the work of the committee.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.
Comments and moderation
- NHS diabetic eye screening services and the National Diabetes Audit join forces to evaluate diabetes care 16 September 2021
- Report published marking 25 years of UK National Screening Committee 15 September 2021
- Valuable feedback from newborn blood spot failsafe solution (NBSFS) survey 14 September 2021